311 related articles for article (PubMed ID: 35769485)
1. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
Kunishita Y; Kirino Y; Tsuchida N; Maeda A; Sato Y; Takase-Minegishi K; Yoshimi R; Nakajima H
Front Immunol; 2022; 13():901063. PubMed ID: 35769485
[TBL] [Abstract][Full Text] [Related]
2. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
Front Immunol; 2022; 13():897722. PubMed ID: 35757758
[TBL] [Abstract][Full Text] [Related]
4. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients.
Khitri MY; Guedon AF; Georgin-Lavialle S; Terrier B; Saadoun D; Seguier J; le Besnerais M; De Moreuil C; Denis G; Gerfaud-Valentin M; Allain JS; Maria A; Bouillet L; Grobost V; Galland J; Kosmider O; Dumont A; Devaux M; Subran B; Schmidt J; Marianetti-Guingel P; Audia S; Palat S; Roux-Sauvat M; Jachiet V; Hirsch P; Fain O; Mekinian A;
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35868738
[TBL] [Abstract][Full Text] [Related]
5. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
Kirino Y; Takase-Minegishi K; Tsuchida N; Hirahara L; Kunishita Y; Yoshimi R; Nakajima H
Ann Rheum Dis; 2021 Nov; 80(11):1501-1502. PubMed ID: 34260381
[No Abstract] [Full Text] [Related]
6. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
[TBL] [Abstract][Full Text] [Related]
7. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the clinical spectrum of relapsing polychondritis: insights into its pathogenesis, novel monogenic causes, and therapeutic strategies.
Bica BERG; de Souza AWS; Pereira IA
Adv Rheumatol; 2024 Apr; 64(1):29. PubMed ID: 38627861
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome.
Goyal A; Narayanan D; Wong W; Laga AC; Connell NT; Ritter SY; Cobos G
JAAD Case Rep; 2022 May; 23():15-19. PubMed ID: 35391910
[No Abstract] [Full Text] [Related]
10. A Case of VEXAS: Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome With Co-existing DNA (Cytosine-5)-Methyltransferase 3A Mutation Complicated by Localized Skin Reaction to Tocilizumab and Azacitidine.
Estes J; Malus M; Wilson L; Grayson PC; Maz M
Cureus; 2023 Jun; 15(6):e39906. PubMed ID: 37404435
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
[TBL] [Abstract][Full Text] [Related]
12. [Macrocytic anemia and polychondritis: VEXAS syndrome].
Zeisbrich M; Schindler V; Krausz M; Proietti M; Mrovecova P; Voll RE; Glaser C; Röther F; Warnatz K; Venhoff N
Z Rheumatol; 2024 Apr; 83(3):229-233. PubMed ID: 36735069
[TBL] [Abstract][Full Text] [Related]
13. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
[TBL] [Abstract][Full Text] [Related]
14. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
[TBL] [Abstract][Full Text] [Related]
15. A man in his sixties with chondritis and bone marrow failure.
Midtvedt Ø; Stray-Pedersen A; Andersson H; Gunnarsson R; Tveten K; Ali MM; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239266
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
Hanioka Y; Shimizu K; Yamagami K; Yao S; Nakamura R; Nakamura T; Goto H
Intern Med; 2021 May; 60(10):1615-1620. PubMed ID: 33281154
[TBL] [Abstract][Full Text] [Related]
17. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
[TBL] [Abstract][Full Text] [Related]
18. French practical guidelines for the diagnosis and management of relapsing polychondritis.
Arnaud L; Costedoat-Chalumeau N; Mathian A; Sailler L; Belot A; Dion J; Morel N; Moulis G;
Rev Med Interne; 2023 Jun; 44(6):282-294. PubMed ID: 37236870
[TBL] [Abstract][Full Text] [Related]
19. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.
Vitale A; Caggiano V; Martin-Nares E; Frassi M; Dagna L; Hissaria P; Sfriso P; Hernández-Rodríguez J; Ruiz-Irastorza G; Monti S; Tufan A; Piga M; Giardini HAM; Lopalco G; Viapiana O; De Paulis A; Triggianese P; Vitetta R; de-la-Torre A; Fonollosa A; Caroni F; Sota J; Conticini E; Sbalchiero J; Renieri A; Casamassima G; Wiesik-Szewczyk E; Yildirim D; Hinojosa-Azaola A; Crisafulli F; Franceschini F; Campochiaro C; Tomelleri A; Callisto A; Beecher M; Bindoli S; Baggio C; Gómez-Caverzaschi V; Pelegrín L; Soto-Peleteiro A; Milanesi A; Vasi I; Cauli A; Antonelli IPB; Iannone F; Bixio R; Casa FD; Mormile I; Gurnari C; Fiorenza A; Mejia-Salgado G; Kawakami-Campos PA; Ragab G; Ciccia F; Ruscitti P; Bocchia M; Balistreri A; Tosi GM; Frediani B; Cantarini L; Fabiani C
Semin Arthritis Rheum; 2024 Jun; 66():152430. PubMed ID: 38554594
[TBL] [Abstract][Full Text] [Related]
20. VEXAS syndrome: a diagnostic puzzle.
Ruffer N; Krusche M
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
